Beta-blocker formulations in oral tablet form for hypertension control. Pharmaceutical companies manufacture and supply to wholesalers, hospitals, and outpatient clinics. Procurement teams acquire from API producers and formulators for integration into cardiovascular treatment regimens in primary care and specialty facilities.